Cellular immune responses of a Senegalese community recently exposed to Schistosoma mansoni: Correlations of infection level with age and inflammatory cytokine production by soluble egg antigen-specific cells

Tropical Medicine and International Health

Volumn 4, Issue 8, 1999, Pages 530-543

  Marguerite, M ^a   Gallissot, M C ^a   Diagne, M ^a   Moreau, C ^b   Diakkhate, M M ^c   Roberts, M ^e   Remoue, F ^a   Thiam, A ^a   Decam, Ch ^a   Rogerie, F ^a   Cottrez, F ^e   Neyrinck, J L ^d   Butterworth, A E ^e   Sturrock, R F ^e   Piau, J P ^c   Daff, B ^a   Niang, M ^a   Wolowczuk, I ^e   Riveau, G ^d   Auriault, Claude ^d   Capron, A ^d   more..

^a Programme ESPOIR   (Senegal)

^b SANOFI   (France)

^c Programme ESPOIR   (Senegal)

^d INSTITUT PASTEUR DE LILLE   (France)

^e NONE

Author keywords

Cytokines; Helminth parasites; Human clinical studies; Th1 Th2

Indexed keywords

IMMUNITY; INFECTIOUS DISEASE; SCHISTOSOMIASIS;

ANTIGEN SPECIFICITY; ARTICLE; CELL PROLIFERATION; CELLULAR IMMUNITY; CORRELATION FUNCTION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EPIDEMIC; FEMALE; HELPER CELL; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; SENEGAL;

ADOLESCENT; ADULT; AGE FACTORS; ANIMALS; ANTIGENS, HELMINTH; CHILD; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; MALE; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; SENEGAL; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TH1 CELLS; TH2 CELLS;

SENEGAL;

SCHISTOSOMA MANSONI; TREMATODA; VERMES;

EID: 0032820744     PISSN: 13602276     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3156.1999.00443.x     Document Type: Article

References (59)

1. Amiri P, Locksley RM, Parslow TG et al. (1992) Tumor necrosis factor a restores granulomas and induces parasite egg laying in schistosome-infected SCID mice. Nature 356, 604-607.
2. Butterworth AE, Dalton PR, Dunne DW et al. (1984) Immunity after treatment of human schistosomiasis mansoni. I. Study design, pretreatment observations and the results of treatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 78, 108-123.
3. Butterworth AE, Capron M, Cordingley JS et al. (1985) Immunity after treatment of human schistosomiasis mansoni. II. Identification of resistant individuals, and analysis of their immune responses. Transactions of the Royal Society of Tropical Medicine and Hygiene 79, 393-408.
4. Butterworth AE, Fulford AJ, Dunne DW et al. (1988) Longitudinal studies on human schistosomiasis. Philosophical Transactions -Royal Society of London Biological Sciences Series B 321, 495-511.
5. Capron A & Dessaint JP (1985) Effector and regulatory mechanisms in immunity to schistosomes: a heuristic view. Annual Review of Immunology 3, 455-476.
6. Capron M & Capron A (1994) Immunoglobulin E and Effector cells in schistosomiasis. Science 264, 1876-1877.
7. Cheever AW, Finkelman FD, Caspar P et al. (1992) Treatment with anti-IL-2 antibodies reduces hepatic pathology and eosinophilia in Schistosoma mansoni-infected mice while selectively inhibiting T cell IL-5 production. Journal of Immunology 148, 3244-3248.
8. Cheever AW, Williams ME, Wynn TA et al. (1994) Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. Journal of Immunology 153, 753-759.
9. Chikunguwo SM, Kanazawa T, Dayal Y et al. (1991) The cell-mediated response to schistosomal antigens at the clonal level. In vivo functions of cloned murine egg antigen-specific CD41 T helper type 1 lymphocytes. Journal of Immunology 147, 3921-3925.
10. Clutterbuck EJ, Hirst EM & Sanderson CJ (1989) Human interleukin-5 (IL-5) regulates the production of eosinophils in human bone marrow cultures: comparison and interaction with IL-1, IL-3, IL-6 and GM-CSF. Blood 73, 1504-1512.
11. Cottrell B, Pye C & Butterworth AE (1989) Cytotoxic effects in vitro of human monocytes and macrophages on schistosomula of Schistosoma mansoni. Parasite Immunology 11, 91-104.
12. Couissinier-Paris P, Bourgeois A, Dessein H et al. (1995) Identification of a major T cell immunogen in the anti-schistosome response of adult residents in an area endemic for Schistosoma mansoni. European Journal of Immunology 25, 903-910.
13. Couissinier-Paris P & Dessein AJ (1995) Schistosoma-specific helper T cell clones from subjects resistant to infection by Schistosoma mansoni are Th0/2. European Journal of Immunology 25, 2295-2302.
14. Damonneville M, Wietzerbin J, Pancrė V et al. (1988) Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvac. Journal of Immunology 140, 3962-3965.
15. De Jonge N, de Caulwe P, Hilberath GW et al. (1989) Circulating anodic antigen levels in serum before and after chemotherapy with praziquantel in schistosomiasis mansoni. Transactions of the Royal Society of Tropical Medicine and Hygiene 83, 368-372.
16. De waal Malefyt R, Abrams F, Bennett B et al. (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. Journal of Experimental Medicine 174, 1209-1220.
17. Dunne DW, Butterworth AE, Fulford AJC et al. (1992) Immunity after treatment of human Schistosomiasis mansoni: association between IgE antibodies to adult worm antigens and resistance to infection. European Journal of Immunology 22, 1483-1494.
18. Flores Villanueva P, Reiser H & Stadecker MJ (1994) Regulation of T helper cell responses in experimental murine schistosomiasis by IL-10. Effect on expression of B7 and B7-2 costimulatory molecules by macrophages. Journal of Immunology 153, 5190-5199.
19. Flores-Villanueva P, Zheng XX, Strom TB et al. (1996) Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen-specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. Journal of Immunology 156, 3315-3320.
20. Grzych JM, Pearce E, Cheever A et al. (1991) Egg deposition is the major stimulus for the production of Th2 cytokines in murine schistosomiasis mansoni. Journal of Immunology 146, 1322-1337.
21. Hagan P, Blumenthal UJ, Dunne D et al. (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349, 243-245.
22. Henderson GS, Lu X, McCurley TL et al. (1992) In vivo molecular analysis of lymphokines involved in the murine immune response during Schistosoma mansoni infection. II. Quantification of IL-4 mRNA, IFN-γ, mRNA and IL-2 mRNA levels in the granulomatous livers, mesenteric lymph nodes, and spleens during the course of modulation. Journal of Immunology 148, 2261-2269.
23. James SL & Nacy C (1993) Effector functions of activated macrophages against parasites. Current Opinion in Immunology 5, 518-523.
24. Katz N, Chaves A & Pellegrino J (1972) A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Revista Do Instituto de Medicina Tropical de Sao Paulo 14, 397-400.
25. Khalife J, Capron M, Capron A et al. (1986) Immunity in human schistosomiasis: regulation of protective immune mechanisms by IgM blocking antibodies. Journal of Experimental Medicine 164, 1626-1640.
26. Khalife J, Dunne D, Richardson BA et al. (1989) Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. Journal of Immunology 142, 4422-4427.
27. King CL, Medhat A, Malhotra I et al. (1996) Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. Journal of Immunology 156, 4715-4721.
28. Lewis WA & Strand M (1991) Characterization of proteins and immunogens released by adult Schistosoma mansoni. Journal of Parasitology 77, 263-271.
29. Mathew RC & Boros DL (1986) Anti-L3T4 antibody treatment suppresses hepatic granuloma formation and abrogates antigen-induced interleukin-2 production in Schistosoma mansoni infection. Infection and Immunity 54, 820-826.
30. Mathew RC, Ragheb S & Boros DL (1990) Recombinant IL-2 therapy reverses diminished granulomatous responsiveness in anti-L3T4-treated, Schistosoma mansoni-infected mice. Journal of Immunology 144, 4356-4361.
31. Modlin RL & Nutman TB (1993) Type 2 cytokines and negative immune regulation in human infections. Current Opinion in Immunology 5, 511-517.
32. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65, 55-63.
33. Mosmann TR & Coffman RL (1989) Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annual Review of Immunology 7, 145-173.
34. Nix N, Lu X, Reis D et al. abstract 102, 41st Annual Meeting of the American Society of Tropical Medicine and Hygiene, Seattle, Washington, November (1992).
35. Pancré V, Joseph M, Mazingue C et al. (1987) Induction of platelet cytotoxic functions by lymphokines: role of interferon-γ. Journal of Immunology 138, 4490-4495.
36. Pancré V, Monté D, Delanoye A et al. (1990) Interleukin-6 is the main mediator of the interaction between monocytes and platelets in the killing of Schistosoma mansoni. European Cytokine Network 1, 15-19.
37. Pearce EJ, Caspar P, Grzych JM et al. (1991) Downregulation of Th1 cytokine production accompanies induction of Th2 responses by a parasitic helminth, Schistosoma mansoni. Journal of Experimental Medicine 173, 159-166.
38. Pemberton RM, Malaquias LCC, Falcao PL et al. (1994) Cell-mediated immunity to schistosomes. Evaluation of mechanisms operating against lung-stage parasites which might be exploited in a vaccine. Tropical and Geographical Medicine 46, 247-254.
39. Picquet M, Ernould JC, Vercruysse J et al. (1996) The epidemiology of human schistosomiasis in the Senegal River Basin. Transactions of the Royal Society of Tropical Medicine and Hygiene 30, 340-346.
40. Poulain-Godefroy O, Gaubert S, Lafitte S et al. (1996) Immunoglobulin A response in murine schistosomiasis: stimulatory role of egg antigens. Infection and Immunity 64, 763-768.
41. Punnonen J, Aversa G, Cocks BG et al. (1993) Interleukin-13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proceedings of the National Academy of Sciences of the USA 90, 3730-3734.
42. Ribeiro de Jesus A, Almeida RP, Bacellar O et al. (1993) Correlation between cell-mediated immunity and degree of infection in subjects living in an endemic area for schistosomiasis. European Journal of Immunology 23, 152-158.
43. Rihet P, Demeure CE, Bourgois A et al. (1991) Evidence for an association between human resistance to Schistosoma mansoni and high anti-larval IgE levels. European Journal Immunology 21, 2679-2686.
44. Roberts M, Butterworth AE, Kimani G et al. (1993) Immunity after treatment of human schistosomiasis: Association between cellular responses and resistance to reinfection. Infection and Immunity 61, 4984-4993.
45. Schumacher JH, O'Garra A, Schrader B et al. (1988) The characterization of four monoclonal antibodies specific for mouse IL-5 and development of mouse and human IL-5 enzyme linked immunosorbent assays. Journal of Immunology 141, 1576-1581.
46. + T lymphocytes correlates with down regulation of Th1 cytokine synthesis in helminth infection. Journal of Immunology 147, 2713-2716.
47. Snapper CM & Mond JJ (1993) Towards a comprehensive view of immunoglobulin class switching. Immunology Today 14, 15-17.
48. Stadecker MJ (1994) The shrinking schistosomal egg granuloma: How accessory cells control T cell-mediated pathology. Experimental Parasitology 79, 198-201.
49. Stelma FF, Talla I, Niang M et al. (1994) Morbidity due to heavy Schistosoma mansoni infection in a recently established focus in northern Senegal. American Journal of Tropical Medicine and Hygiene 50, 575-579.
50. Stelma FF, Talla I, Polman K et al. (1993) Epidemiology of Schistosoma mansoni infection in a recently exposed community in northern Senegal. American Journal of Tropical Medicine and Hygiene 49, 701-706.
51. Sturrock RE, Bensted-Smith R, Butterworth AE et al. (1987) Immunity after treatment of human schistosomiasis mansoni. III. Long term effects of treatment and retreatment. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 303-314.
52. Talla I, Kongs A & Verlé P (1992) Preliminary study of the prevalence of human schistosomiasis in Richard-Toll (the Senegal River Basin). Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 182.
53. Talla I, Kongs A, Verlé P et al. (1990) Outbreak of intestinal schistosomiasis in the Senegal River Basin. Annales de la Société Belge de Médecine Tropicale 70, 173-180.
54. Van Snick J (1990) Interleukin-6: an overview. Annual Review of Immunology 8, 253-278.
55. Van Snick J, Cayphas S, Vinck A et al. (1986) Purification and NH2-termitial amino acid sequence of a cell-derived lymphokine with growth activities for B-cell hybridomas. Proceedings of the National Academy of Sciences of the USA 83, 9679-9683.
56. Veith MC & Butterworth AE (1983) Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvac by mononuclear cell products in vitro. Journal of Experimental Medicine 157, 1828-1843.
57. Wilkins HA, Blumenthal UJ, Hagan P et al. (1987) Resistance to reinfection after treatment of urinary schistosomiasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 81, 29-35.
58. Yamashita T & Boros DL (1992) IL-4 influences IL-2 production and granulomatous inflammation in murine Schistosomiasis mansoni. Journal of Immunology 149, 3659-3364.
59. Zurawski G & de Vries JE (1994) Interleukin-13, an interleukin-4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunology Today 15, 19-26.